AdAlta Competitors and Similar CompaniesClear all

AdAlta's competitors and similar companies include Roche, Teva Pharmaceuticals, Biogen and Samumed.
AdAlta
AdAlta
AdAlta is a drug discovery and development company intended to generate a new class of protein therapeutics, known as i-bodies.
Roche
Roche
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
Teva Pharmaceuticals
Teva Pharmaceuticals
Teva Pharmaceuticals is a global pharmaceutical company.
Biogen
Biogen
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
Samumed
Samumed
Samumed is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation.
Founding Date
Founding Date
2006
Founding Date
1896
Founding Date
1901
Founding Date
1978
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Bundoora, AU HQ
Melbourne, AU
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
North Ryde, AU
Sydney, AU
Wien, AT
Dhaka, BD
see more
Locations
Petah Tikva, IL HQ
Villa Adelina, AR
Macquarie Park, AU
Minsk, BY
Antwerpen, BE
Sao Paulo, BR
Dupnica, BG
see more
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paul, BR
Toronto, CA
see more
Locations
San Diego, US HQ
San Diego, US
Employees
Employees
9
Employees
103,249
Employees
37,000
Employees
7,605
Employees
1701% increase
Valuation ($)
Valuation ($)
7.2 m
Valuation ($)
N/A
Valuation ($)
20.8 b
Valuation ($)
26.7 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
CHF61.5b (FY, 2025)
Revenue (est.)
$17.3b (FY, 2025)
Revenue (est.)
$9.9b (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
CHF13.1b (FY, 2025)
Cost of goods
$8.3b (FY, 2025)
Cost of goods
$2.4b (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
$677k (FY, 2025)
Gross profit
CHF50.5b (FY, 2025)
Gross profit
$8.9b (FY, 2025)
Gross profit
$7.5b (FY, 2025)
Gross profit
N/A
Net income
Net income
($4.5m) (FY, 2025)
Net income
CHF13.8b (FY, 2025)
Net income
$1.4b (FY, 2025)
Net income
$1.3b (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 3m
Total funding raised
$ 7.8b
Total funding raised
$ 358m
Total funding raised
N/A
Total funding raised
$ 438m
For sources of this data, please see the company profile

View Company Profiles

Roche
HQ
Basel, CH
Employees
103,249

Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.

View company
Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
37,000

Teva Pharmaceuticals is a global pharmaceutical company.

View company
Biogen
HQ
Cambridge, US
Employees
7,605

Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.

View company
Samumed
HQ
San Diego, US
Employees
170↑ 1% increase

Samumed is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation.

View company